Skip to main content

Pharmacy

By Beth Jones Sanborn | 05:22 pm | January 31, 2018
The increase represents a substantial impact, especially given the use of many high-cost drugs, the report says. The firm also points to biosimilars as opportunity to thwart spending.
By Bernie Monegain | 05:32 pm | January 18, 2018
Advisors to the ambitious plan include former CMS head Don Berwick, MD, and Harvard professor Clayton Christensen, among others.
By Susan Morse | 04:50 pm | January 09, 2018
The former Eli Lilly CEO also told the Senate Finance Committee affordability and the opioid epidemic round out his top four priorities.
By Susan Morse | 12:13 pm | January 04, 2018
Opioids and heroin play a big role, but so do variations in primary care and mental health services.
By Susan Morse | 11:59 am | December 28, 2017
The most important developments hospital finance and operations executives should understand heading into 2018.
By Beth Jones Sanborn | 01:11 pm | December 26, 2017
Raymond Kraynak doled out millions of opioids without a "legitimate medical purpose," DOJ says.
By Susan Morse | 11:41 am | December 08, 2017
Providers, insurers are among those closely watching for signs of online giant getting into pharmaceutical business.
By Jeff Lagasse | 04:42 pm | December 06, 2017
Report says U.S. could achieve lower prices for prescription drugs by consolidating its bargaining power and providing greater flexibility in formulary design.
By Jeff Lagasse | 02:14 pm | December 06, 2017
Injuries resulting from medication use are among the most common types of inpatient injuries at U.S. hospitals, affecting hundreds of thousands of patients every year.
By Susan Morse | 03:35 pm | December 01, 2017
CMS said it would cover the test to make the targeted therapy options available to healthcare professionals, patients and eligible Medicare beneficiaries‎.